Target intelligence / Profile preview

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 2 (EEF1A1P2)

Target
EEF1A1P2
Molecular classification
Pseudogene
01

Overview

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 2 (EEF1A1P2) is a pseudogene derived from the parental gene EEF1A1. While EEF1A1 encodes the essential translation elongation factor eEF1A1 involved in protein synthesis, EEF1A1P2 does not encode a functional protein and lacks confirmed biological or clinical function. Most pseudogenes, including EEF1A1P2, do not produce proteins, and no regulatory RNA roles have been established for EEF1A1P2. It is classified as a processed pseudogene, arising mostly by retrotransposition or segmental duplication. It is crucial not to confuse EEF1A1P2 with the functional EEF1A1 gene or its protein product eEF1A1. Pseudogenes like EEF1A1P2 are generally not considered therapeutic targets. There are no established disease associations, drug interactions, or biomarker statuses for EEF1A1P2 itself; these are only relevant to the coding parental gene or its functional isoforms. The parental gene EEF1A1 is widely expressed and implicated in many cell processes and diseases, including cancer, but none of these roles apply to EEF1A1P2.

Other names
EEF1A1P2Eukaryotic translation elongation factor 1 alpha 1 pseudogene 2
02

Biological functions

No known protein-coding functionNot known to play an active biological role as a pseudogeneNo confirmed biological or clinical functionDoes not produce a functional protein
03

Disease associations

No established role in disease for the pseudogeneNo established disease associations for EEF1A1P2 itself

Beyond the preview

Go deeper on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 2 (EEF1A1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 2 (EEF1A1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call